Displays the article's font size
Increase the font size for the article
Canada's Public Health has publicly identified Oxalo as the “independent third-party administrator” of VISP, highlighting the arms leadership relationship between the government and contractors.
This was the reason why PHAC outsourced VISP management in the first place. This is to avoid a potential conflict of interest between their roles as promoters and approvers of the Covid-19 vaccine and as administrators of another program that provides financial support to those injured by the shot.
Despite claims that VISPs are independent, the PHAC communications strategy of the Vaccine Injury Support Program reveals that PHAC and Oxaro (formerly RCGT Consulting) regularly consult each other before answering questions about the program, or questions about the cases of VISP claimants asked by Journalist or members of the Congress.
An excerpt from PHAC emails obtained under the Access to Information Act.
Global News
The second document shows that PHAC and Oxaro have agreed to jointly develop a VISP funding agreement called the “Cooperative Litigation Management Plan.”
Get weekly health news
Receive the latest medical news and health information provided every Sunday.
The plan calls for them to work together “to mitigate the risk of litigation.” This could be initiated against the agency or company, the document says.
A copy of the PHAC funding agreement was obtained under the Access to Information Act.
Trend now
Convicted murderer Lori Bill Jerma flees from Quebec's Alcambaud facility
Canadians' choices are when businesses push back to their offices
Two pages of the 2021 government funding agreement between the Canadian Public Health Agency and Oxalo (then called the Raymond Chabot Grant Thornton Consulting) show that they have agreed to develop a litigation management plan.
Global News
Global News suggested to Oxalo that such arrangements suggest that consulting firms are not entirely independent managers.
Oxalo's written response? “Please address this question to PHAC.”
When Global News asked the PHAC, the agency's repeated responses were, “VISP is managed independently and distributed by Oxalo.”
